Share

May 09, 2017; 88 (19) Article

Probable REM sleep behavior disorder and risk of stroke

A prospective study

Chaoran Ma, Milena Pavlova, Yesong Liu, Ying Liu, Chunmei Huangfu, Shouling Wu, Xiang Gao
First published April 7, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003902
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
206

Share

Article Information

vol. 88 no. 19 1849-1855
DOI: 
https://doi.org/10.1212/WNL.0000000000003902
PubMed: 
28389588
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 10, 2016
  • Accepted in final form February 17, 2017
  • First Published April 7, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Chaoran Ma, MD,
    2. Milena Pavlova, MD,
    3. Yesong Liu, MD,
    4. Ying Liu, MD,
    5. Chunmei Huangfu, MD,
    6. Shouling Wu, MD and
    7. Xiang Gao, MD, PhD
  1. Chaoran Ma, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Milena Pavlova, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. Partial support from the Parkinson's Disease foundation for travel to RBD study planning meeting - May 2011. Not related to current study

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Effects of Clobazam on sleep and daytime function in patients with epilepsy Source: Lundbeck pharm. Type of support: research grant

    Research Support, Government Entities:

    1. Breathing abnormalities during seizures Harvard CATALYST Program Role: Principal Investigator Goals: To evaluate the abnormalities of breathing in adults and children with epilepsy (completed 2011) Effects of Clobazam on sleep and daytime function in patients with epilepsy Role: Principal Investigator Goals: To determine whether treatment with clobazam (a benzodiazepine) of patients with seizures leads to a more consolidated sleep and as a result, a better daytime function 2016 Use of Bioboosti for Insomnia Treatment ? a pilot study Role: Principal investigator Goals: to determine preliminary efficacy of a non- pharmacologic treatment option for insomnia

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Yesong Liu, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ying Liu, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Chunmei Huangfu, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Shouling Wu, MD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Xiang Gao, MD, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Nutritional Sciences (C.M., X.G.), The Pennsylvania State University, University Park; Department of Neurology (M.P.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Departments of Neurology (Yesong Liu, Ying Liu, C.H.) and Cardiology (S.W.), Kailuan General Hospital, Tangshan, China.
  1. Correspondence to Dr. Gao: xxg14{at}psu.edu or Dr. Wu: drwusl{at}163.com
View Full Text

Article usage

Article usage: April 2017 to December 2022

AbstractFullPdfSource
Apr 20171348031Highwire
May 201717162239Highwire
Jun 201726099Highwire
Jul 201713734Highwire
Aug 20176324Highwire
Sep 20174900Highwire
Oct 20176013Highwire
Nov 20175765Highwire
Dec 20175823Highwire
Jan 20189556Highwire
Feb 20186843Highwire
Mar 20185911Highwire
Apr 20184721Highwire
May 20186723Highwire
Jun 20182413Highwire
Jun 20187119pmc
Jul 20182711Highwire
Aug 20182600Highwire
Aug 2018478pmc
Sep 20181302Highwire
Oct 20184022Highwire
Nov 20189100Highwire
Dec 20181911Highwire
Jan 20193721Highwire
Feb 20192100Highwire
Mar 20192901Highwire
Apr 20193830Highwire
May 20193326Highwire
Jun 20191613Highwire
Jul 20192622Highwire
Aug 20192200Highwire
Sep 20191317Highwire
Oct 20191901Highwire
Nov 20191911Highwire
Dec 20192842Highwire
Jan 20202624Highwire
Feb 20204012Highwire
Mar 20202602Highwire
Apr 20203900Highwire
May 20203741Highwire
Jun 20204401Highwire
Jul 20203900Highwire
Aug 20203101Highwire
Sep 20203504Highwire
Oct 20203400Highwire
Nov 20202610Highwire
Dec 20204902Highwire
Jan 20214502Highwire
Feb 20213814Highwire
Mar 20214701Highwire
Apr 20213931Highwire
May 20215001Highwire
Jun 20213613Highwire
Jul 20213300Highwire
Aug 20214502Highwire
Sep 20214611Highwire
Oct 20217402Highwire
Nov 20214310Highwire
Dec 20214700Highwire
Jan 20226701Highwire
Feb 20225011Highwire
Mar 20225100Highwire
Apr 20226300Highwire
May 20223311Highwire
Jun 20224301Highwire
Jul 20227901Highwire
Aug 20227034Highwire
Sep 20223220Highwire
Oct 20226511Highwire
Nov 20224400Highwire
Dec 20222900Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me